Professor of Healthcare Management and Director of the Center for Healthcare Management, Germany, and Columbia University, New York, USA
Katharina Janus, a professor of healthcare management in Germany and at Columbia University New York, is the founder and managing director of the Center for Healthcare Management and the president and CEO of the consulting network ENJOY STRATEGY. She has twenty years of global healthcare management experience in science and corporate practice. Starting her career in managed care at one of the largest hospital chains in the United States, she has learned about challenges on the shop floor before turning to academia where she continued to pursue applied research. She then left her tenured position in Germany to lead the Center for Healthcare Management and reinvent research and education that is in constant dialogue with practice. Her global consulting network ENJOY STRATEGY supports many of the Center’s projects on the implementation side. As a keynote speaker and moderator, she frequently contributes her global domain expertise and indepth knowledge of healthcare markets and trends. In this respect, she has helped major multinational companies with market access strategy and business development to facilitate on-site implementation in various cultural environments. Dr. Janus was a 2006-07 Harkness Fellow in Health Care Policy at The Commonwealth Fund, a Rockefeller Foundation academic fellow in 2012 and a Brocher Foundation resident in 2014. She was also one of the youngest tenured professors and female board members of a DAX company appointed in Germany. Dr. Janus earned her Master’s Degree in Business Administration at the Universities of Hamburg and the Université Panthéon-Sorbonne Paris in 2000. She holds a PhD in Business and Social Sciences from Helmut-Schmidt-University in Hamburg (2003) and the German qualification as a full professor (2009). She has been a ballet dancer before she started her career in healthcare management which inspired her to create sculptures whenever her busy schedule permits. Her creative approaches to strategy consulting frequently are influenced by her artistic upbringing and education.
Hospital director and associate professor at SciencesPo, Paris, France
I hold 20 years of management experience in healthcare and strategic operations where I have led many projects in the French or international business environment. My work has brought me to co-direct with health professionals important projects in leading hospitals in Paris and Africa. Further, I have collaborated with stakeholders from many nationalities such as from private or public sector and since 1996 I teach Social Policies at Sciences Po Paris as Associate Professor.
For the past four years, I have led the implementation of lean innovation standards within three major programs in the Hospitals of Paris (AP-HP), introduced best-practices in continuous improvement and improved team dynamics-objectives that I have also reached in my preceding management roles across a specific HIV Program or some other infrastructure projects.
Recent projects achieved include: improving safety, quality and strategic clinical pathways within Radiology departments, Hospital at Home, Optimizing the Performance of Billing Departments – includes the complete consolidation of AP-HP assets. Those projects relied on patient engagement and health workers experience expression, quality and security standards, rapid improvement events, use in routine of metrics, design of inputs monitoring and evaluation system.
To sustain the scaling up of Innovation management within AP-HP, I lead a specific educational program for strengthening the capacities of the team and health workers.
Though my professional career has been primarily based in Paris, I regularly share lessons and experiences with colleagues and suppliers across EU, USA and Africa.
Since 2015, I work with the scandinavian staff about the concentration Innovation streaming and financing in public and private sector.
Founder and CEO of medAspis GmbH
Ralf Däinghaus, born 1967, is the founder and CEO of medAspis GmbH and an expert regarding the implementation of the Falsified Medicines Directive. Ralf has spent a large part of his career in the pharmaceutical supply chain, including the creation of DocMorris in 1999, when he was the CEO of the company for 10 years. At the time, DocMorris was a pioneer in pharmaceutical mail order, today DocMorris is Europe’s largest mail order pharmacy.
The resistance from the established suppliers was great. The company was taken to the European Court of Justice twice, which decided that DocMorris has the right to follow its path. While at DocMorris, Ralf had won the German founder price and received some important economics awards.
Today, Ralf innovates and improves the logistic pitfalls created by the implementation of the FMD. His extensive experience in the pharma logistics industry was the base of creation and designing medAspis system. As a result, medAspis does not offer a technical connection like so many others, but a complete platform including optimal integration into existing processes and documentation which can be attached to reports for the competent authorities.
Ralf was and is an entrepreneur by description. After completing his studies in IT, he started his career as an entrepreneur. He is successful with his own companies and has never been employed for a longer period of time.
Chief Economist of Allianz SE, Munich, Germany
Michael Heise is Chief Economist of Allianz SE. He advises the board of Allianz SE on economic and strategic issues. He is responsible for analysis and forecasts of the German and the international economy and the financial markets and risk analysis. Heise studied and graduated at Cologne University and lectured at the European Business School in Oestrich-Winkel and at the Johann Wolfgang Goethe University in Frankfurt-am-Main. He is honorary professor at the Johann Wolfgang Goethe University. Before joining Allianz Group, Heise was Secretary General of the German Council of Economic Experts, Chief Economist of the DG Bank and Chief Economist and Head of Research at DZ Bank.
Walter C. Kopp
President, Medical Management Services, San Anselmo, CA, USA
Walter Kopp is President of Medical Management Services a healthcare executive management and advisory group specializing in the development of clinically integrated communities. This group has assisted with medical group practice management, medical group and hospital integration, physician succession planning, managed care analysis and contracting, and healthcare technology implementation in Health Systems. Services also include strategic positioning and market analysis, medical group development, contract negotiations, service line development and operations reviews.
A partial list of MMS recent clients include; Sutter Health, City of Hope Medical Group, Blue Shield of California, The Permanente Medical Group, Alta Bates Medical Group, Brown and Toland Medical Group, Hill Physicians Medical Group, Anthem/ Blue Cross of California, St Joseph Heritage Medical Foundation, Santa Rosa Memorial Hospital, Marin General Hospital, Lodi Memorial Community Clinics, Torrance Memorial Medical Center, Salinas Valley Healthcare District, Palm Drive Healthcare District, the American College of Surgeons and Cardiovascular Consultants Medical Group.
Previously, Walter was Chief Operating Officer of Menlo Clinic at Stanford University Medical Center. Walter was also Executive Director of BayCare Medical Group and Assistant VP and Director at St. Luke’s Hospital in San Francisco. In addition, he worked for large accounting firms, Alta Bates Hospital, University of Colorado Hospital, UC San Francisco, and the Ross Valley Medical Group.
Walter has served on various boards of Directors, including the National IPA Coalition, Marin Community Clinic, and the Bay Pacific Health Plan. Walter is founder and current advisor to the California eHealth Collaborative. He earned his BA degree from the University of California, Berkeley and his Masters in Health Administration from the University of Colorado.
Vice President, Strategic Relations and Managed Care Sales, Medimpact
Ray Marsella joined MedImpact in 2014 as Vice President, Strategic Relations, with more than 20 years of experience in healthcare and pharmacy benefit management. Mr. Marsella has previously served as Regional Vice President for the commercial division of Express Scripts, Inc. At ESI he was responsible for a region comprising 300 clients with two million covered lives and generating $158 million in gross margin. While at Merck Medco, Mr. Marsella was instrumental in helping secure and install a $1 billion contract with United Healthcare that required him to build effective relationships with key executives and create methods for conversion of operations. He has supported diverse books of business consisting of third party administrators, Fortune 100 employers and national health plans. His diverse background enables him to drive success with cross-functional teams consisting of clinical, technical, sales and account team members, creating and implementing innovative solutions. Mr. Marsella has a Bachelor of Science degree in economics from Montclair State University in Montclair, New Jersey.
Chief Executive Officer, InGeneron, USA
Angelo Moesslang is Chief Executive Officer of InGeneron, a privately held US-based clinical stage cell therapy company. The Company has developed and is working to market a medical device platform that enables novel, evidence-based treatments designed to heal certain chronic musculoskeletal conditions using a patient’s own regenerative cells. InGeneron has introduced its system into the U.S. Food and Drug Administration’s regulatory process to ensure it is safe and effective. Successfully attaining FDA approval will allow InGeneron to market the regenerative cell therapy for specific indications in the United States.
Angelo has more than 20 years of executive-level leadership experience in the medical device and health care industry in Europe, Asia-Pacific and the U.S.. Prior to joining InGeneron, he served as chief financial officer of Fresenius Medical Care North America Holdings, the U.S.-based division of Fresenius Medical Care, a global medical device and health care services group. As member of the executive team he helped create and manage a multi-billion dollar portfolio of different medical device, pharma and healthcare service businesses and business models. Earlier roles in Angelo’s career include CFO for Fresenius Medical Care Europe, Africa, Middle East, and Latin America; vice president business development for Asia Pacific; and head of investor relations for Fresenius Medical Care.
Angelo holds a doctorate in business administration and a master’s degree in economics. He lives in Boston, USA and Munich, Germany.
CEO AMEOS Hospital Group, Zurich
Axel Paeger, M.D., has served as CEO of AMEOS Hospital Group since 2003. Prior to his current position, Dr. Paeger was chief managing officer of Asklepios Kliniken GmbH. Before that, he was a member of the Pacific Health Corporation, Inc. board. He has also served as an associate partner for Health Care Consultancy in Cleveland, OH, USA.
AMEOS is among Europe’s leading healthcare service providers and primarily serves German speaking regions (with today 68 facilities in the fields of hospitals, long-term mental care facilities and long-term elderly care facilities).
Associate Executive Director, The Permanente Medical Group
Stephen Parodi, MD serves an associate executive director for The Permanente Medical Group located in Northern California that serves over 4 million patients and members. He has responsibility for hospital operations, inpatient quality, patient safety, care of complex and special needs populations, skilled nursing facilities, home health, hospice, and external communications. He also serves as executive vice president for The Permanente Federation, the organization which represents 22,000 physicians who practice at Kaiser Permanente throughout the US. His duties include external affairs, government relations, communications, and brand. He also serves as a liaison for Kaiser Permanente’s engagement in local and international healthcare delivery initiatives.
Dr. Parodi received his medical degree from Georgetown University, completed his internal medicine residency at Vanderbilt University Medical Center, and infectious disease fellowship at the UCLA Affiliated Program in Infectious Disease. He practices as an infectious disease physician and has a special interest in population and community health as well as applied epidemiology. He actively collaborates with the California Department of Public Health and Centers for Disease Control on public health matters.
He has led clinical projects related to the reduction of healthcare acquired infections, antimicrobial stewardship, reduction in dialysis related infections, and regional outbreak responses. His work in hospital operations has included programs such as enhanced recovery after surgery, patient blood management, observation medicine, and bedside multidisciplinary rounding. Special interests now include addressing the social determinants of health to scale and transforming outpatient acute home care.
President of Medef, Ile-de-France Region, Paris, France, and the head of Business European Capital Cities
Jean-Louis Schilansky, a French National, is a civil mining engineer with a degree in Chemical Engineering. He spent most of his career in the Oil Industry in the International Downstream sector first with Mobil and then with Exxon Mobil. He held several senior positions including Vice-President and President of Mobil Europe until the merger with Exxon. After returning to France, he joined UFIP the French National Oil Industry Association, first as Executive Director and then as President. In parallel he became a Vice President of Medef, the French Business Confederation where he chaired its Energy Committee. He also served as chairman of the Economic Activities section of the French Social, Economic and Environmental National Council. Currently he is President of Medef Paris/ Grand Paris. Jean-Louis Schilansky is a Chevalier de la Légion d’Honneur.
Chief Medical Officer, Canopy Growth, Canada
Mark Ware is currently the Chief Medical Officer of Canopy Growth Corporation. He has taken a leave of absence as Associate Professor in Family Medicine and Anesthesia at McGill University from July 2018 to work in this capacity. He previously served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years, and was the Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids since 2007. He has served as co-director of the FRQS-supported Quebec Pain Research Network, and sat on the executive management team of the Alan Edwards Centre for Research on Pain at McGill University. His research has been funded and supported by CIHR, FRQS, private foundations and pharmaceutical companies. He has published over 100 papers on cannabis and pain research in academic journals, has written 6 book chapters, and has given hundreds of lectures to health professionals and the public on cannabis over the last 20 years. He has served as a consultant to several large corporate and academic research programs internationally. He has advised the Canadian federal government on cannabis policy since 2001, and 2016, he served as the vice chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada.